0001415889-13-001351.txt : 20130709 0001415889-13-001351.hdr.sgml : 20130709 20130709170014 ACCESSION NUMBER: 0001415889-13-001351 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130701 FILED AS OF DATE: 20130709 DATE AS OF CHANGE: 20130709 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Echo Therapeutics, Inc. CENTRAL INDEX KEY: 0001031927 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 411649949 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 8 PENN CENTER STREET 2: 1628 JFK BLVD, SUITE 300 CITY: PHILADELPHIA STATE: PA ZIP: 19103 BUSINESS PHONE: 215-717-4100 MAIL ADDRESS: STREET 1: 8 PENN CENTER STREET 2: 1628 JFK BLVD, SUITE 300 CITY: PHILADELPHIA STATE: PA ZIP: 19103 FORMER COMPANY: FORMER CONFORMED NAME: SONTRA MEDICAL CORP DATE OF NAME CHANGE: 20020702 FORMER COMPANY: FORMER CONFORMED NAME: CHOICETEL COMMUNICATIONS INC/MN/ DATE OF NAME CHANGE: 20020701 FORMER COMPANY: FORMER CONFORMED NAME: SONTRA MEDICAL CORP DATE OF NAME CHANGE: 20020701 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ENRIGHT VINCENT D CENTRAL INDEX KEY: 0001247208 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-35218 FILM NUMBER: 13960178 MAIL ADDRESS: STREET 1: ONE CORPORATE CENTER CITY: RYE STATE: NY ZIP: 10580 4/A 1 form4a-07092013_050706.xml X0306 4/A 2013-07-01 2013-07-02 0001031927 Echo Therapeutics, Inc. ECTE 0001247208 ENRIGHT VINCENT D 8 PENN CENTER 1628 JFK BLVD, SUITE 300 PHILADELPHIA PA 19103 true false false false Common Stock 2013-07-01 4 A 0 400 0 A 13300 D Nonqualified Stock Option (right to buy) 2.49 2013-07-01 4 A 0 1500 0 A 2014-07-01 2023-07-01 Common Stock 1500 13000 D The shares vest on July 1, 2014, provided, however that all unvested Restricted Shares shall immediately vest upon the sale of or substantially all of the assets of the Company of all or substantially all of the outstanding capital stock of the Company in exchange for Liquid Proceeds. As used herein, "Liquid Proceeds" shall mean (a) cash; (b) securities which can be sold immediately on NYSE or NASDAQ; (c) securities which are or will be registered such that they can be sold upon on NYSE or NASDAQ upon termination of a lock-up period not to exceed one hundred eighty (180) days; or (d) or a combination of cash and the foregoing securities. This amendment to Form 4 is to properly reflect beneficial ownership following a 1 for 10 reverse stock split on June 7, 2013. The transactions reported on the Form 4 dated July 1, 2013 were accurate. The Options vest on July 1, 2014; provided, however, that all unvested Options shall immediately vest upon the sale of all or substantially all of the assets of the Company or all or sustainably all of the outstanding capital stock of the Company in exchange for Liquid Proceeds. /s/ Kimberly A. Burke, Attorney-in-Fact 2013-07-09